Promising safety and pharmacokinetic data on BT051 for UC Presented ByDr Chris Stevens, Bacainn Therapeutics, Clinical Development, Concord, United States TrialPhase 1 ConferenceECCO 2021 TypeNews article 2 July 2021 22:37